Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: A retrospective matched pairs comparison
Autor: | Ellinor Haukland, Bård Mannsåker, Carsten Nieder, Adam Pawinski, Kirsten Engljähringer, Astrid Dalhaug |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Adult
Male medicine.medical_specialty Palliative care Multivariate analysis Lung Neoplasms medicine.medical_treatment Matched-Pair Analysis Bone Neoplasms Quality of life Palliative team Internal medicine Carcinoma Non-Small-Cell Lung medicine Palliative radiotherapy Humans Radiology Nuclear Medicine and imaging Survival rate Aged Neoplasm Staging Retrospective Studies Aged 80 and over Performance status business.industry Brain Neoplasms VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762 Research Cancer Retrospective cohort study Radiotherapy Dosage Middle Aged medicine.disease Prognosis Surgery Radiation therapy Survival Rate VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 Oncology Radiology Nuclear Medicine and imaging Quality of Life Female business Supportive care Follow-Up Studies |
Zdroj: | Radiation Oncology (London, England) |
Popis: | License: Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) Purpose: To analyze survival after early palliative radiotherapy (RT) in patients managed exclusively by regular oncology staff or a multidisciplinary palliative care team (MPCT) in addition. Methods: Retrospective matched pairs analysis. Comparison of two groups of 29 patients each: MPCT versus none. Early RT started within three months after cancer diagnosis. Results: Bone and brain metastases were common RT targets. No significant differences in baseline characteristics were observed between both groups. Twelve patients in each group had non-small cell lung cancer. Median performance status was 2 in each group. Twenty-seven patients in each group had distant metastases. Median survival was not significantly different. In multivariate analysis, MPCT care was not associated with survival, while performance status and liver metastases were. Rate of radiotherapy during the last month of life was comparable. Only one patient in each group failed to complete radiotherapy. Conclusions: MPCT care was not associated with survival in these two matched groups of patients. The impact of MPCT care on other relevant endpoints such as symptom control, side effects and quality of life should be investigated prospectively. |
Databáze: | OpenAIRE |
Externí odkaz: |